4-hydroxytamoxifen enhances stemness through the neuropilin-1/estrogen-related receptor alpha pathway to enhance breast cancer cell paclitaxel resistance and metastasis

4-hydroxytamoxifen enhances stemness through the NRP/ERRα pathway to enhance breast cancer cell PTX resistance and metastasis.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacy and Pharmacology
Published
2026-01-20
DOI
https://doi.org/10.1093/jpp/rgag007
Primary Topic
Cancer, Stress, Anesthesia, and Immune Response
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

4-hydroxytamoxifen enhances stemness through the neuropilin-1/estrogen-related receptor alpha pathway to enhance breast cancer cell paclitaxel resistance and metastasis

Lu Chen, Li Zhang, Yanni Lv, Qinglong Yu
Journal of Pharmacy and Pharmacology
Cancer, Stress, Anesthesia, and Immune Response
article

4-hydroxytamoxifen enhances stemness through the neuropilin-1/estrogen-related receptor alpha pathway to enhance breast cancer cell paclitaxel resistance and metastasis

Lu Chen, Li Zhang, Yanni Lv, Qinglong Yu
article en

Abstract

4-hydroxytamoxifen enhances stemness through the NRP/ERRα pathway to enhance breast cancer cell PTX resistance and metastasis.

Journal of Pharmacy and PharmacologyVol. 78(2)
Yantai University (CN), Yuhuangding Hospital (CN)
Good health and well-being
Openalex Percentile: Top 62%
Cancer, Stress, Anesthesia, and Immune Response
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

4-hydroxytamoxifen enhances stemness through the neuropilin-1/estrogen-related receptor alpha pathway to enhance breast cancer cell paclitaxel resistance and metastasis — Lu Chen, Li Zhang, et al. · Journal of Pharmacy and Pharmacology (2026) | TGRS Research Map | TGRS